Home > companies > news > Sanofi held talks with Abbott, Mylan for mature products sale

Geneva: Sanofi has held talks with Mylan Inc., Abbott Laboratories and private-equity firms including Warburg Pincus LLC about a possible sale of its mature products portfolio, according documents circulated by a labour union.

The project to carve out 200 Sanofi mature products with about €2.1 billion (about 17,100 crore) in estimated sales was nicknamed Phoenix in a company presentation dated 6 May, the documents circulated by a representative of the CGT union showed.

No decision has been made yet on the product portfolio, Jack Cox, a spokesman for Sanofi in Paris, said on Wednesday.

Mylan this week said it was buying Abbott Laboratories’ generic-drug business in established markets like Europe and forming a new company that would be incorporated in the Netherlands, cutting its taxes. Bloomberg

With assistance from Simeon Bennett in Geneva.

Subscribe to newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaper Livemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

My Reads Logout